Interventional Oncology Market: By Product ), Ablation Devices Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Other Ablation Devices), Support Devices, By Procedure, By Cancer Type, By End User and Geography
Interventional Oncology Market size was valued at US$ 2.1 billion in 2023. It is expected to reach a value of US$ 3.2 billion by 2029, growing at a CAGR of 6.8% from 2024 to 2030. The global market provides a detailed overview of the market, which has been segmented by product, ablation device, support devices, procedure, cancer type, and end user. The market has been segmented into In Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents (Microspheres, Coated Beads, Microparticles). The Embolization Devices segment is likely the most significant and fastest-growing segment in various products. By ablation devices, the market has been segmented into Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Other Ablation Devices.
The Radiofrequency (RF) Ablation Devices are expected to account for a significant revenue share during the forecast period. Support devices have segmented the market into Microcatheters, Guidewires. The Microcatheters accounted for a substantial revenue share in 2021. By Procedure, the market has been segmented into Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization.
Thermal Tumor Ablation is expected to hold a significant revenue share during the forecast period. The market has been segmented by cancer types: Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, and Other Cancers. The liver cancer segment holds the largest revenue share of the market. Based on the End User, Interventional Oncology is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.
Study Period
2024-2030Base Year
2023CAGR
6.8%Largest Market
North AmericanFastest Growing Market
Asia-Pacific
According to the World Health Organization (WHO), cancer kills 8.3 million people annually, with 70 % of new cancer cases likely to be recorded in the next 20 years. A rise in cancer patients is expected to be a significant market driver.
The interventional oncology market is divided into five geographic segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In terms of region, North America held the largest market share for interventional oncology worldwide in 2021.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2.1 billion |
|
Market Size in 2029 |
US$ 3.2 billion |
|
Market CAGR |
6.8% |
|
By Product |
|
|
By Procedure |
|
|
By Cancer Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Interventional oncology market size was valued at US$ 2.1 billion in 2023 and is set to reach US$ 3.2 billion by 2029, at a CAGR of 6.8% from 2024-2030.
The major global Interventional Oncology market players are ??? Medtronic, AngioDynamics, HealthTronics, Boston Scientific, J&J, BD, Teleflex, Terumo, Cook Medical, and Merit Medical.
North American is the fastest-growing region for Interventional Oncology Market
| 1. Executive Summary |
| 2. Global Interventional Oncology Market Introduction |
| 2.1. Global Interventional Oncology Market - Taxonomy |
| 2.2. Global Interventional Oncology Market -Definitions |
| 2.2.1. By Product |
| 2.2.2. By Procedure |
| 2.2.3. By Cancer Type |
| 2.2.4. By End User |
| 2.2.5. By Region |
| 3. Global Interventional Oncology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Interventional Oncology Market Dynamic Factors - Impact Analysis |
| 3.6. Global Interventional Oncology Market - Competition Landscape |
| 4. Global Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Interventional Oncology Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Embolization Devices |
| 5.1.1. Radioembolic Agents |
| 5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Non-Radio embolic Agents |
| 5.1.2.1. Microspheres |
| 5.1.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.1.3. Market Opportunity Analysis |
| 5.1.2.2. Coated Beads |
| 5.1.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.2.3. Market Opportunity Analysis |
| 5.1.2.3. Microparticles |
| 5.1.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3.3. Market Opportunity Analysis |
| 5.2. Ablation Devices |
| 5.2.1. Radiofrequency (RF) Ablation Devices |
| 5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Microwave Ablation Devices |
| 5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. Cryoablation Devices |
| 5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 5.2.4. Other Ablation Devices |
| 5.2.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.4.3. Market Opportunity Analysis |
| 5.3. Support Devices |
| 5.3.1. Microcatheters |
| 5.3.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.1.3. Market Opportunity Analysis |
| 5.3.2. Guidewires |
| 5.3.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.2.3. Market Opportunity Analysis |
| 6. Global Interventional Oncology Market, By Procedure, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Thermal Tumor Ablation |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Non-Thermal Tumor Ablation |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transcatheter Arterial Chemoembolization |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Transcatheter Arterial Embolization/Bland Embolization |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Interventional Oncology Market, By Cancer Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Liver Cancer |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Lung Cancer |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Bone Metastasis |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Kidney Cancer |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Breast Cancer |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Prostate Cancer |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Other Cancers |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8. Global Interventional Oncology Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Ambulatory Surgery Centers |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Research & Academic Institutes |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Interventional Oncology Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Region, 2024 - 2030 |
| 10. North America Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Embolization Devices |
| 10.1.1.1. Radioembolic Agents |
| 10.1.1.2. Non-Radio embolic Agents |
| 10.1.1.2.1. Microspheres |
| 10.1.1.2.2. Coated Beads |
| 10.1.1.2.3. Microparticles |
| 10.1.2. Ablation Devices |
| 10.1.2.1. Radiofrequency (RF) Ablation Devices |
| 10.1.2.2. Microwave Ablation Devices |
| 10.1.2.3. Cryoablation Devices |
| 10.1.2.4. Other Ablation Devices |
| 10.1.3. Support Devices |
| 10.1.3.1. Microcatheters |
| 10.1.3.2. Guidewires |
| 10.2. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Thermal Tumor Ablation |
| 10.2.2. Non-Thermal Tumor Ablation |
| 10.2.3. Transcatheter Arterial Chemoembolization |
| 10.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 10.2.5. Transcatheter Arterial Embolization/Bland Embolization |
| 10.3. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Liver Cancer |
| 10.3.2. Lung Cancer |
| 10.3.3. Bone Metastasis |
| 10.3.4. Kidney Cancer |
| 10.3.5. Breast Cancer |
| 10.3.6. Prostate Cancer |
| 10.3.7. Other Cancers |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospitals |
| 10.4.2. Ambulatory Surgery Centers |
| 10.4.3. Research & Academic Institutes |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2024 - 2030 |
| 10.7. North America Interventional Oncology Market Dynamics - Trends |
| 11. Europe Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Embolization Devices |
| 11.1.1.1. Radioembolic Agents |
| 11.1.1.2. Non-Radio embolic Agents |
| 11.1.1.2.1. Microspheres |
| 11.1.1.2.2. Coated Beads |
| 11.1.1.2.3. Microparticles |
| 11.1.2. Ablation Devices |
| 11.1.2.1. Radiofrequency (RF) Ablation Devices |
| 11.1.2.2. Microwave Ablation Devices |
| 11.1.2.3. Cryoablation Devices |
| 11.1.2.4. Other Ablation Devices |
| 11.1.3. Support Devices |
| 11.1.3.1. Microcatheters |
| 11.1.3.2. Guidewires |
| 11.2. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Thermal Tumor Ablation |
| 11.2.2. Non-Thermal Tumor Ablation |
| 11.2.3. Transcatheter Arterial Chemoembolization |
| 11.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 11.2.5. Transcatheter Arterial Embolization/Bland Embolization |
| 11.3. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Liver Cancer |
| 11.3.2. Lung Cancer |
| 11.3.3. Bone Metastasis |
| 11.3.4. Kidney Cancer |
| 11.3.5. Breast Cancer |
| 11.3.6. Prostate Cancer |
| 11.3.7. Other Cancers |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospitals |
| 11.4.2. Ambulatory Surgery Centers |
| 11.4.3. Research & Academic Institutes |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2024 - 2030 |
| 11.7. Europe Interventional Oncology Market Dynamics - Trends |
| 12. Asia-Pacific Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Embolization Devices |
| 12.1.1.1. Radioembolic Agents |
| 12.1.1.2. Non-Radio embolic Agents |
| 12.1.1.2.1. Microspheres |
| 12.1.1.2.2. Coated Beads |
| 12.1.1.2.3. Microparticles |
| 12.1.2. Ablation Devices |
| 12.1.2.1. Radiofrequency (RF) Ablation Devices |
| 12.1.2.2. Microwave Ablation Devices |
| 12.1.2.3. Cryoablation Devices |
| 12.1.2.4. Other Ablation Devices |
| 12.1.3. Support Devices |
| 12.1.3.1. Microcatheters |
| 12.1.3.2. Guidewires |
| 12.2. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Thermal Tumor Ablation |
| 12.2.2. Non-Thermal Tumor Ablation |
| 12.2.3. Transcatheter Arterial Chemoembolization |
| 12.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 12.2.5. Transcatheter Arterial Embolization/Bland Embolization |
| 12.3. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Liver Cancer |
| 12.3.2. Lung Cancer |
| 12.3.3. Bone Metastasis |
| 12.3.4. Kidney Cancer |
| 12.3.5. Breast Cancer |
| 12.3.6. Prostate Cancer |
| 12.3.7. Other Cancers |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospitals |
| 12.4.2. Ambulatory Surgery Centers |
| 12.4.3. Research & Academic Institutes |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2024 - 2030 |
| 12.7. Asia-Pacific Interventional Oncology Market Dynamics - Trends |
| 13. Latin America Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Embolization Devices |
| 13.1.1.1. Radioembolic Agents |
| 13.1.1.2. Non-Radio embolic Agents |
| 13.1.1.2.1. Microspheres |
| 13.1.1.2.2. Coated Beads |
| 13.1.1.2.3. Microparticles |
| 13.1.2. Ablation Devices |
| 13.1.2.1. Radiofrequency (RF) Ablation Devices |
| 13.1.2.2. Microwave Ablation Devices |
| 13.1.2.3. Cryoablation Devices |
| 13.1.2.4. Other Ablation Devices |
| 13.1.3. Support Devices |
| 13.1.3.1. Microcatheters |
| 13.1.3.2. Guidewires |
| 13.2. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Thermal Tumor Ablation |
| 13.2.2. Non-Thermal Tumor Ablation |
| 13.2.3. Transcatheter Arterial Chemoembolization |
| 13.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 13.2.5. Transcatheter Arterial Embolization/Bland Embolization |
| 13.3. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Liver Cancer |
| 13.3.2. Lung Cancer |
| 13.3.3. Bone Metastasis |
| 13.3.4. Kidney Cancer |
| 13.3.5. Breast Cancer |
| 13.3.6. Prostate Cancer |
| 13.3.7. Other Cancers |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospitals |
| 13.4.2. Ambulatory Surgery Centers |
| 13.4.3. Research & Academic Institutes |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2024 - 2030 |
| 13.7. Latin America Interventional Oncology Market Dynamics - Trends |
| 14. Middle East and Africa Interventional Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Embolization Devices |
| 14.1.1.1. Radioembolic Agents |
| 14.1.1.2. Non-Radio embolic Agents |
| 14.1.1.2.1. Microspheres |
| 14.1.1.2.2. Coated Beads |
| 14.1.1.2.3. Microparticles |
| 14.1.2. Ablation Devices |
| 14.1.2.1. Radiofrequency (RF) Ablation Devices |
| 14.1.2.2. Microwave Ablation Devices |
| 14.1.2.3. Cryoablation Devices |
| 14.1.2.4. Other Ablation Devices |
| 14.1.3. Support Devices |
| 14.1.3.1. Microcatheters |
| 14.1.3.2. Guidewires |
| 14.2. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Thermal Tumor Ablation |
| 14.2.2. Non-Thermal Tumor Ablation |
| 14.2.3. Transcatheter Arterial Chemoembolization |
| 14.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy |
| 14.2.5. Transcatheter Arterial Embolization/Bland Embolization |
| 14.3. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Liver Cancer |
| 14.3.2. Lung Cancer |
| 14.3.3. Bone Metastasis |
| 14.3.4. Kidney Cancer |
| 14.3.5. Breast Cancer |
| 14.3.6. Prostate Cancer |
| 14.3.7. Other Cancers |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospitals |
| 14.4.2. Ambulatory Surgery Centers |
| 14.4.3. Research & Academic Institutes |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Interventional Oncology Market - Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2024 - 2030 |
| 14.7. MEA Interventional Oncology Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Boston Scientific Corporation |
| 15.2.2. Medtronic PLC |
| 15.2.3. Terumo Corporation |
| 15.2.4. Merit Medical Systems Inc. |
| 15.2.5. CR Bard Inc. |
| 15.2.6. Profound Medical Corp. |
| 15.2.7. AngioDynamics Inc. |
| 15.2.8. Cook Medical LLC |
| 15.2.9. HealthTronics Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
